Vargas F, Osuna A, Fernández-Rivas A
Departamento de Fisiología, Facultad de Medicina de Granada, Spain.
J Hypertens. 1996 Mar;14(3):373-9. doi: 10.1097/00004872-199603000-00015.
The purpose of this study was to determine the contribution of the functional changes in resistance vessels to the hypertension induced by chronic nitric oxide synthase inhibition in rats. Another goal of this study was to evaluate whether this model of hypertension is accompanied by changes in the activity of endothelium-derived hyperpolarizing factor (EDHF).
Hypertension was induced by long-term (6 weeks) oral administration of N-nitro-L-arginine methyl ester (L-NAME; 75 mg/100 ml in the drinking fluid). Vascular reactivity to vasoconstrictors (phenylephrine and barium chloride) and vasodilators (acetylcholine and nitroprusside) and the flow-pressure curve were examined in isolated perfused kidneys preparations. Vascular reactivity to vasoconstrictors and the flow-pressure curve were studied under basal conditions or after the infusion of L-arginine (100 mumol/l). The activity of EDHF was evaluated by comparing the dose-response curves for acetylcholine obtained in potassium chloride- and phenylephrine-preconstricted preparations.
Kidneys from L-NAME-induced hypertensive rats showed increased sensitivity to vasoconstrictors with a greater duration of the pressor responses at high doses and markedly up-shifted flow-pressure curve in comparison with that obtained in control kidneys. These differences disappeared when the kidneys from control and L-NAME-treated rats were infused with L-arginine. The kidneys from L-NAME-treated rats also showed a decreased responsiveness to acetylcholine with an augmented reactivity to nitroprusside. The acetylcholine dose-response curve was reduced in control preparations and greatly attenuated in L-NAME-treated preparations when the renal vasculature was preconstricted with potassium chloride.
The changes in vascular reactivity observed in L-NAME-induced hypertensive rats may play an important role in the pathogenesis of this type of hypertension. Moreover, it is also suggested that long-term nitric oxide inhibition may be associated with increased activity of EDHF.
本研究旨在确定阻力血管功能变化对慢性一氧化氮合酶抑制诱导的大鼠高血压的作用。本研究的另一个目标是评估这种高血压模型是否伴有内皮源性超极化因子(EDHF)活性的变化。
通过长期(6周)口服N-硝基-L-精氨酸甲酯(L-NAME;饮水中75毫克/100毫升)诱导高血压。在离体灌注肾制备物中检测血管对血管收缩剂(去氧肾上腺素和氯化钡)和血管舒张剂(乙酰胆碱和硝普钠)的反应性以及流量-压力曲线。在基础条件下或输注L-精氨酸(100微摩尔/升)后研究血管对血管收缩剂的反应性和流量-压力曲线。通过比较在氯化钾和去氧肾上腺素预收缩制备物中获得的乙酰胆碱剂量反应曲线来评估EDHF的活性。
与对照肾相比,L-NAME诱导的高血压大鼠的肾对血管收缩剂的敏感性增加,高剂量时升压反应持续时间更长,且流量-压力曲线明显上移。当给对照和L-NAME处理大鼠的肾输注L-精氨酸时,这些差异消失。L-NAME处理大鼠的肾对乙酰胆碱的反应性也降低,对硝普钠的反应性增强。当肾血管系统用氯化钾预收缩时,对照制备物中的乙酰胆碱剂量反应曲线降低,而在L-NAME处理的制备物中大大减弱。
在L-NAME诱导的高血压大鼠中观察到的血管反应性变化可能在这种类型高血压的发病机制中起重要作用。此外,还表明长期抑制一氧化氮可能与EDHF活性增加有关。